Stevanato Group S.p.A (STVN) Cash & Equivalents (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Cash & Equivalents of $130.7 million for Q1 2026, up 37.01% year-over-year from $95.4 million in Q1 2025, and down 14.0% quarter-over-quarter from $152.0 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash & Equivalents (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Cash & Equivalents for 7 consecutive years, with $130.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents rose 37.01% year-over-year to $130.7 million; the TTM figure through Mar 2026 stood at $130.7 million (up 37.01% YoY), while the FY2025 annual figure was $152.0 million, up 44.73% from the prior year.
- Cash & Equivalents slipped to $130.7 million in Q1 2026 per STVN's latest filing, from $152.0 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $411.6 million in Q1 2022 and bottomed at $66.7 million in Q2 2023.
- Historically, Cash & Equivalents has averaged $160.0 million across 5 years, with a median of $130.7 million in 2026.
- Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 176.85% — and 2023, when it tumbled 80.16%.
- Stevanato Group S.p.A's Cash & Equivalents stood at $233.4 million in 2022, then sank by 67.91% to $74.9 million in 2023, then surged by 40.27% to $105.0 million in 2024, then surged by 44.73% to $152.0 million in 2025, then retreated by 14.0% to $130.7 million in 2026.
- Business Quant data shows STVN's Cash & Equivalents at $130.7 million in Q1 2026, $152.0 million in Q4 2025, and $132.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 708.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.33 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 91.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 91.41 Mn |
| Mar 31, 2026 | 130.74 Mn |
| Dec 31, 2025 | 152.03 Mn |
| Sep 30, 2025 | 132.49 Mn |
| Jun 30, 2025 | 106.60 Mn |
| Mar 31, 2025 | 95.42 Mn |
| Dec 31, 2024 | 105.04 Mn |
| Sep 30, 2024 | 85.66 Mn |
| Jun 30, 2024 | 84.15 Mn |
| Mar 31, 2024 | 202.42 Mn |
| Dec 31, 2023 | 74.89 Mn |
| Sep 30, 2023 | 70.56 Mn |
| Jun 30, 2023 | 66.67 Mn |
| Mar 31, 2023 | 170.41 Mn |
| Dec 31, 2022 | 233.37 Mn |
| Sep 30, 2022 | 262.08 Mn |
| Jun 30, 2022 | 336.03 Mn |
| Mar 31, 2022 | 411.55 Mn |
| Dec 31, 2021 | 470.22 Mn |
| Sep 30, 2021 | 504.70 Mn |